NCM treatment decreases hepatic CoQ₁₀, but increases total cholesterol and cholesterol ester levels, which is associated with significant decreases in the expressions of... by Ryan J. Mailloux (50825)

Subjects: “…mitochondrial ATP synthase subunit ATP 5A…”

S5 Fig - by Jordan K. Abbott (8934239)

Anandamide decreases locomotor activity and rearing in small open field. by Adriaan W. Bruijnzeel (2605954)

Refinement of scrambles, with no USM decreases, no W. by Jedediah M. Singer (10331212)

Decreased TNIP1 expression in SSc patients. by Yannick Allanore (58641)

“…<p>(A) Expression of the TNIP1 protein was decreased ex vivo in SSc lesional skin tissue compared to controls (arrows indicate TNIP-1 positive cells). …”

Decreased growth of <i>S</i>. <i>aureus</i> CBS2016-05 and PS/BAC/317/16/W during PC storage in comparison to trypticase soy broth (TSB). by Basit Yousuf (630368)

Increase of Viral Dose and Addition of Mosquito Salivary Gland Extracts (SGE) Decrease circulating Viral RNA. by Anne M. Wertheimer (359266)

The ABD of βI-spectrin decreases the morphological plasticity of dendritic spines. by Michael W. Nestor (231215)

Light levels needed to produce a given response relative to that of the maximin response in intensity–response curves (Fig 4). by Richard W. Brill (2337940)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

Increases in 1,5-anhydrosorbitol and decreases in ascorbic acid following RYGB. by David M. Mutch (37665)

“…B) For ascorbic acid, the ANOVA model did not detect group-specific changes over time (no group:time interaction), but indicated significant decreases from T0 to T6 in both groups. Overall, 1,5-anhydrosorbitol and ascorbic acid were significantly different at each time point between OB and OB/D subgroups (p<0.01, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-t002" target="_blank"><b>TABLE 2</b></a>).…”

Deletion of <i>Kdm5b</i> in DCs leads to increased cytokine production and decreased Th2 pathology <i>in vivo</i>. by Catherine Ptaschinski (756139)

BECN1 knockdown and BCL-W/BCL2 co-inhibition decreases cell proliferation through increased apoptosis in resistant cells. by Anatasha C. Crawford (255140)

Unusual [3+1] Cycloaddition of a Stable Silylene with a 2,3-Diazabuta-1,3-diene versus [4+1] Cycloaddition toward a Buta-1,3-diene by Yun Xiong (1403545)

“…The latter rearranges further to decrease ring strain, affording the corresponding 1-sila-4,5-diazacyclohex-3-ene <b>4</b>. …”

Naringenin decreases total cell viability. by Lauren A. Eanes (20995499)

Hsp72 overexpression decreases total NF-κB-p65 in resting cells and reduces steady state IκBα protein levels. by Patrick W. Sheppard (586664)

“…Gray data points are rescaled from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1003471#pcbi-1003471-g001" target="_blank">Fig. 1B</a>. …”

L586W mutation decreases cyclic nucleotide affinity to the C-linker/CNBDs of HCN2 channels. by Sebastien Hayoz (388817)

Overview of study procedures. by Matthew G. Vinson (22593374)

“…VIDEO and CONTROL were associated with a similar rise in intent to decrease OTC NSAID use (1.92 (SD: 4.41) vs. 1.36 (SD: 3.46), p = 0.150) and a similar decrease in NSAIDs exposure (−32.8% in VIDEO and −36.5% in CONTROL, p = 0.520) 4 weeks post-intervention. …”

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

28 days of testosterone depletion decreases fiber CSA only in the TA muscle and only at 1.5-month-old mice. by Arik Davidyan (10450896)